Navigation Links
SCOLR Pharma Announces Unaudited Net Sales of Nutritional Products
Date:6/20/2012

BOTHELL, Wash., June 20, 2012 /PRNewswire/ -- SCOLR Pharma, Inc. (PINK: SCLR) today reported unaudited net sales of its nutritional products for the fourth quarter and year ended December 31, 2011 and the first quarter ended March 31, 2012. 

Unaudited net sales of nutritional products were $252,000 for both the fourth quarter and year ended December 31, 2011.  Unaudited net sales of nutritional products were $454,000 for the first quarter ended March 31, 2012. 

SCOLR announced the first shipments of its nutritional products in December 2011 and did not record net sales of nutritional products for the first three quarters of 2011.  SCOLR's products, which are based on the Company's proprietary CDT® Controlled Delivery Technology platform, are sold directly to retailers in the mass consumer products channel and are available to consumers under private label and the SCOLR® CDT® brand-name.  

Stephen Turner, President and CEO of SCOLR, said: "We are gratified to see our direct sales and marketing efforts begin to generate revenues and repeat sales.  We are working with retailers to expand the number and type of products available to consumers and we hope to continue the current momentum into the remainder of this launch year.  The proceeds of our recently closed financing will be used primarily to fund inventory and promotional needs in support of these efforts. We will continue to focus on our short term goal of profitably growing and stabilizing our nutritional business, while preparing for the eventual commercialization of our ibuprofen product."

SCOLR recently announced the closing of a private placement financing in which it raised gross proceeds of $1.35 million through the sale of its 8% Secured Convertible Debentures due June 2013. 

About SCOLR Pharma:

Based in Bothell, Washington, SCOLR Pharma, Inc. is a specialty pharmaceutical company focused on a
'/>"/>

SOURCE SCOLR Pharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. SCOLR Pharma Welcomes Clem Calabrese as Director of Field Sales
2. Optimer Pharmaceuticals and Specialised Therapeutics Australia Collaborate to Commercialize Fidaxomicin for Clostridium difficile Infection in Australia and New Zealand
3. CPhI South America 2012 Returns to Brazil with One of a Kind Pharma Event
4. ADVENTRX Pharmaceuticals To Present At 2012 BIO International Convention Business Forum
5. Michael Cola Joins the Board of Directors of Vanda Pharmaceuticals
6. Sentry BioPharma Services Invests in Global Clinical Supply Services with -45C Freezer Expansion
7. Debiopharm and Ascepion Pharmaceuticals, Inc. Announce an Exclusive License Agreement for the Development and Commercialisation of the Dual-Targeting Kinase Inhibitor, ASP-08126 (Debio 1144), for the Treatment of Oncology Diseases
8. Oregon State University Launches New Online Learning System For Pharmacy Managers
9. Tris Pharma to Hold Job Fairs - Saturday, June 16 and Saturday, June 23
10. Cumberland Pharmaceuticals To Present At The 2012 Wells Fargo Securities Healthcare Conference In Boston
11. NABP Applies for New .PHARMACY Generic Top-Level Domain to Provide a Secure Destination for Consumers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... Calif. , July 24, 2014  IRIDEX Corporation ... will release its second quarter 2014 financial results after ... In conjunction with the release, the Company will ... 5:00 p.m. Eastern Time on Thursday, ... the quarter and other business developments. Interested ...
(Date:7/24/2014)... 2014 Omnicell, Inc. (NASDAQ: ... supply management solutions and analytics software for healthcare ... to discuss the Company,s Second Quarter 2014 financial ... earnings conference call and webcastWhen: , July ... chairman, president and chief executive officer ...
(Date:7/24/2014)... (NYSE MKT: IG), a New Jersey based specialty generic drug ... second quarter ended June 30, 2014. Second Quarter ... in the second quarter of 2014, an increase of 70% ... of $13.3 million for the six months ended June 30, ... 2013 , Total revenues generated from the sale of ...
Breaking Medicine Technology:Omnicell to Release Second Quarter 2014 Earnings Results on July 31 2IGI Laboratories Announces Second Quarter 2014 Results 2IGI Laboratories Announces Second Quarter 2014 Results 3IGI Laboratories Announces Second Quarter 2014 Results 4IGI Laboratories Announces Second Quarter 2014 Results 5IGI Laboratories Announces Second Quarter 2014 Results 6IGI Laboratories Announces Second Quarter 2014 Results 7
... Control, WASHINGTON, Jan. 10 To help ... risks during times,of health crisis, DuPont (NYSE: ... products, DuPont(TM) Corian(R) solid surface, has been selected,by ... The product,recently was incorporated into a children,s ward ...
... South Korea, Jan. 10 Celltrion, Inc., a ... and CSL Limited, Australia,s leading biopharmaceutical,company, announced today ... supply of CSL 360, an experimental monoclonal antibody ... Phase I clinical trials for CSL,360 are currently ...
Cached Medicine Technology:DuPont Provides Technology for Washington Hospital Center's Emergency Department 2DuPont Provides Technology for Washington Hospital Center's Emergency Department 3DuPont Provides Technology for Washington Hospital Center's Emergency Department 4Celltrion and CSL Announce Collaboration to Develop and Manufacture Monoclonal Antibody 2
(Date:7/25/2014)... Florida Hospital and MOSI officially announced a transformational partnership that ... and make a difference in the Tampa Bay community. Florida ... provide the support needed to keep the science center moving ... IMAX Dome Theatre from film to a state-of-the-art digital 3D ... in the state of Florida, and it is one of ...
(Date:7/25/2014)... 2014 (HealthDay News) -- The human brain can preserve ... a new study finds. Although dehydration significantly ... have found that the brain compensates by increasing the ... "This research has helped us understand a lot more ... in extreme conditions," study first author Steven Trangmar, a ...
(Date:7/25/2014)... AttorneyOne.com, a recognized authority on law, update the ... on Ibuprofen and Oxcarbazepine Tablets . , The ... and one lot of Oxcarbazepine Tablets, by American Health Packaging ... is used for the treatment of certain types of seizures ... the recall is that Lot #142588, Expiration Date, 01/2016 of ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 A new study ... revealed that 39 percent of all children in the survey ... , The survey looked at 2,505 children during the years of ... four years of age. The final result was that about ... care. Many of these children were from lower-income families and were ...
(Date:7/25/2014)... 25, 2014 A new study of participants ... which are published today in Cancer , found evidence ... 74 who had an abnormal finding on a lung cancer ... of life than did those who were screened and found ... surprise to the researchers. “We expected that participants with an ...
Breaking Medicine News(10 mins):Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 2Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 3Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 4Health News:Human Brain Has Coping Mechanism for Dehydration 2Health News:Ibuprofen and Oxcarbazepine Tablets Recalled: AttorneyOne Monitors and Keep Consumers Informed 2Health News:North York Dental Provides Services to Toronto Children in Light of Growing Demand 2Health News:North York Dental Provides Services to Toronto Children in Light of Growing Demand 3Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 2Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 3Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 4Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 5
... PHILADELPHIA Researchers have made an important step ... autism spectrum disorders. A researcher collaboration, including geneticists ... and The Children,s Hospital of Philadelphia (CHOP), have ... responsible for neurological development, learning and memory, which ...
... As part of Jani-King International, a worldwide leader in ... to fight swine flu influenza A (H1N1) in schools, ... that the number of reported cases in the United ... from trips to Mexico, many schools have shut down ...
... School explains how and why the swine flu virus is threatening humans ... , ... Boston, MA (Vocus) April 28, 2009 -- A new report from ... threatening humans and describes what to do if the infection reaches your ...
... Barnes of Greenway Medical Technologies and Chairman of HIMSS Electronic Health ... Proper Guidelines for Meaningful EHR UseCARROLLTON, Ga., April 28 ... , A total ... will address key aspects of certified electronic health record (EHR) ...
... FRANCISCO, April 28 DIAKADI Body, Personal ... kick off its summer outdoor workout series, the hottest and ... the month of June, individuals of all fitness levels will ... to take on the DIAKADI way of training! The outdoor ...
... provider of healthcare on-demand patient and staff education, healthcare televisions ... Hospital East, in Louisville, KY. , ... ... -- TeleHealth Services , the nation,s leading provider of ...
Cached Medicine News:Health News:Penn Medicine, CHOP researchers demonstrate first common genetic risk factors for autism 2Health News:Jani-King of Cleveland Ready to Fight Swine Flu 2Health News:Harvard Medical School Releases Special Health Report on Swine Flu 2Health News:Health IT Experts Assemble in Washington D.C. to Present Testimony on Definition of Meaningful Use Before National Committee on Vital and Health Statistics (NCVHS) 2Health News:Health IT Experts Assemble in Washington D.C. to Present Testimony on Definition of Meaningful Use Before National Committee on Vital and Health Statistics (NCVHS) 3Health News:Health IT Experts Assemble in Washington D.C. to Present Testimony on Definition of Meaningful Use Before National Committee on Vital and Health Statistics (NCVHS) 4Health News:SF Outdoor Workout Series: Definitely Not Your Typical Boot Camp! 2Health News:SF Outdoor Workout Series: Definitely Not Your Typical Boot Camp! 3Health News:TeleHealth Services Chosen by Baptist Hospital East in Development of New Park Tower 2Health News:TeleHealth Services Chosen by Baptist Hospital East in Development of New Park Tower 3Health News:TeleHealth Services Chosen by Baptist Hospital East in Development of New Park Tower 4
... In vitro diagnostic reagents for ... (CRP) in human serum as well ... means of particle-enhanced Immunonephelometry using the ... increased levels of a number of ...
Peapod Rongeur, 5.5 length 140 mm....
Suitable for children and adults. New mechanical design of the skull pin holder and the clamp base ensures improved rigid skull fixation....
The Skull Pins are inserted into the receptacles of the Skull Clamp and fixate the head during surgery....
Medicine Products: